Ifosfamide, Doxorubicin and Hypofractionated Radiotherapy in Neoadjuvant Sarcoma Treatment
NCT02812654
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Sarcoma, Soft Tissue
Interventions
DRUG:
Doxorubicin
DRUG:
Ifosfamide
RADIATION:
radiotherapy
Sponsor
AC Camargo Cancer Center